Clinical Trial Update: A Single-Center Exploratory Study to Assess the Activity of CRx-197-002 in Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 exploratory trial completed evaluating the activity of CRx-197-002 in plaque psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• CRx-197-002

Snippet

Sponsor: Zalicus | Conditions: Plaque Psoriasis | Phase 2 | Status: COMPLETED